Ignite Creation Date:
2024-05-06 @ 7:17 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05969184
Status:
RECRUITING
Last Update Posted:
2023-08-01
First Post:
2022-12-14
Brief Title:
Palbociclib Combine With Anti-HER2 Therapy in Triple Positive ABC
Sponsor:
Organization:
Peking University Cancer Hospital Institute